NYSE ARCA | ETF
The fund invests primarily in equity securities, principally common and preferred stocks of companies of any market capitalization.
Under normal market conditions, the fund invests at least 80% of its net assets, plus borrowings for investment purposes, in securities of companies principally engaged in the research, development, production, or distribution of products and services related to the health care industry ("health care companies").
It is non-diversified.
Top 20 Holdings
| Asset | Name | Sector | Industry | Weight |
|---|---|---|---|---|
| LLY | Eli Lilly and Company | Healthcare | Drug Manufacturers - General | 19.63% |
| ASND | Ascendis Pharma AS | Healthcare | Biotechnology | 15.13% |
| ABBV | AbbVie Inc | Healthcare | Drug Manufacturers - General | 5.23% |
| PCVX | Vaxcyte Inc | Healthcare | Biotechnology | 4.90% |
| ISRG | Intuitive Surgical Inc | Healthcare | Medical Instruments & Supplies | 4.46% |
| INSM | Insmed Inc | Healthcare | Biotechnology | 4.25% |
| LEGN | Legend Biotech Corp | Healthcare | Biotechnology | 4.12% |
| RYTM | Rhythm Pharmaceuticals Inc | Healthcare | Biotechnology | 4.09% |
| AAVXF | ABIVAX Société Anonyme | Healthcare | Biotechnology | 3.63% |
| SNY | Sanofi ADR | Healthcare | Drug Manufacturers - General | 3.55% |
| HUM | Humana Inc | Healthcare | Healthcare Plans | 2.87% |
| DHR | Danaher Corporation | Healthcare | Diagnostics & Research | 2.63% |
| GILD | Gilead Sciences Inc | Healthcare | Drug Manufacturers - General | 2.47% |
| 6XC | SOLENO THERAPEUT. DL-001 | Healthcare | Biotechnology | 2.39% |
| NTRA | Natera Inc | Healthcare | Diagnostics & Research | 2.36% |
| CVS | CVS Health Corp | Healthcare | Healthcare Plans | 2.32% |
| RVMD | Revolution Medicines Inc | Healthcare | Biotechnology | 2.28% |
| COR | Cencora Inc. | Healthcare | Medical Distribution | 2.28% |
| WGS | GeneDx Holdings Corp. | Healthcare | Diagnostics & Research | 2.27% |
| MLTX_old | Multex Com Inc | Other | Other | 2.25% |